Musculoskeletal system-bone and bone marrow and intraosseous, percutaneous approach

85813800 Level 3 · Class Category

35 items in this category

  • 85813802Introduction of analgesics, hypnotics, sedatives into bones, percutaneous approach
    Exempt
  • 85813823Introduction of analgesics, hypnotics, sedatives into joints, percutaneous approach
    Exempt
  • 85813810Introduction of anti-inflammatory into bones, percutaneous approach
    Exempt
  • 85813830Introduction of anti-inflammatory into joints, percutaneous approach
    Exempt
  • 85813801Introduction of destructive agent into bones, percutaneous approach
    Exempt
  • 85813821Introduction of destructive agent into joints, percutaneous approach
    Exempt
  • 85813808Introduction of electrolytic and water balance substance into bones, percutaneous approach
    Exempt
  • 85813828Introduction of electrolytic and water balance substance into joints, percutaneous approach
    Exempt
  • 85813835Introduction of liquid brachytherapy radioisotope into joints, percutaneous approach
    Exempt
  • 85813807Introduction of local anesthetic into bones, percutaneous approach
    Exempt
  • 85813827Introduction of local anesthetic into joints, percutaneous approach
    Exempt
  • 85813817Introduction of monoclonal antibody into bone marrow, percutaneous approach
    Exempt
  • 85813813Introduction of monoclonal antibody into bones, percutaneous approach
    Exempt
  • 85813833Introduction of monoclonal antibody into joints, percutaneous approach
    Exempt
  • 85813809Introduction of nutritional substance into bones, percutaneous approach
    Exempt
  • 85813829Introduction of nutritional substance into joints, percutaneous approach
    Exempt
  • 85813811Introduction of other anti-infective into bones, percutaneous approach
    Exempt
  • 85813819Introduction of other anti-infective into joints, open approach
    Exempt
  • 85813831Introduction of other anti-infective into joints, percutaneous approach
    Exempt
  • 85813818Introduction of other antineoplastic into bone marrow, percutaneous approach
    Exempt
  • 85813814Introduction of other antineoplastic into bones, percutaneous approach
    Exempt
  • 85813834Introduction of other antineoplastic into joints, percutaneous approach
    Exempt
  • 85813803Introduction of other diagnostic substance into bones, percutaneous approach
    Exempt
  • 85813824Introduction of other diagnostic substance into joints, percutaneous approach
    Exempt
  • 85813822Introduction of other gas into joints, percutaneous approach
    Exempt
  • 85813816Introduction of other therapeutic substance into bone marrow, percutaneous approach
    Exempt
  • 85813805Introduction of other therapeutic substance into bones, percutaneous approach
    Exempt
  • 85813826Introduction of other therapeutic substance into joints, percutaneous approach
    Exempt
  • 85813812Introduction of oxazolidinones into bones, percutaneous approach
    Exempt
  • 85813820Introduction of oxazolidinones into joints, open approach
    Exempt
  • 85813832Introduction of oxazolidinones into joints, percutaneous approach
    Exempt
  • 85813804Introduction of radioactive substance into bones, percutaneous approach
    Exempt
  • 85813825Introduction of radioactive substance into joints, percutaneous approach
    Exempt
  • 85813806Introduction of recombinant bone morphogenetic protein into bones, percutaneous approach
    Exempt
  • 85813815Introduction of recombinant bone morphogenetic protein into joints, percutaneous approach
    Exempt
← Back to search